Latest Strategic Partnership News

EV Resources has partnered with U.S.-based MineMaker LLC to accelerate its antimony projects in Mexico and Nevada, aiming to become a key supplier to North America’s critical minerals market.

Li-S Energy narrows its loss to $1.21 million in H1 2026, propelled by a $7.8 million ARENA grant and key manufacturing milestones including Australia’s first lithium metal foil production line. Strategic defence and aerospace partnerships bolster its commercialisation drive.

Aquirian Limited has reported a strong rebound to profitability in the half year ending December 2025, driven by robust revenue growth and strategic partnerships that position it for expansion in mining services.

Mineral Resources Limited reports a dramatic turnaround with a $573 million half-year profit, driven by Onslow Iron’s ramp-up and stronger lithium markets. The company reaffirms FY26 guidance amid strategic joint ventures and balance sheet strengthening.

Talga Group’s application for a major Swedish government grant was declined due to budget constraints, yet the company remains on track with alternative financing to scale its graphite anode production.

MoneyMe Limited reported a 17.2% rise in gross revenue and a 43.7% reduction in net loss for the half-year to December 2025, underpinned by strong loan book growth and enhanced funding capacity.

Jameson Resources has marked significant progress in advancing its Crown Mountain steelmaking coal project, doubling its pre-tax NPV to US$942 million and moving closer to final environmental approvals and development permits expected by the end of 2026.

PLS Group reported a robust first half of FY26, with lithium production up 6% and a 40% jump in realised prices driving a 47% revenue increase. Underlying EBITDA soared 241%, underscoring operational efficiency and cost discipline.

Rhythm Biosciences reported a $2.26 million half-year loss as it advances ColoSTAT into commercialisation and expands geneType partnerships, signalling a pivotal phase for the ASX-listed medical diagnostics company.

Knosys Limited reported a 4.6% revenue increase to $5.07 million for the half-year ending December 2025, driven by stronger licence and project fees. However, the company’s net loss widened significantly to $1.53 million, reflecting heavy investment in its next-generation Libero X library management system.

Cleo Diagnostics has chosen Bio-Techne’s next-generation Ella™ platform to enhance its ovarian cancer blood test, aiming for faster, more precise results and a streamlined path to FDA approval.

EV Resources has successfully produced its first metallic antimony ingots from the Los Lirios project in Mexico, validating a low-cost smelting process and advancing its strategy to supply the North American market.